CBD in Morocco: not individually verified
We have not confirmed that CBD specifically is scheduled in Morocco, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.
- What is on record
- Not confirmed. This substance is in no entry of tableaux A, B or C annexed to the dahir of 2 December 1922 as annexed in 1922, read complete in the ONSSA consolidated text on 22 September 2026, and in no entry of tableaux I to IV of the 1971 Convention as printed at Bulletin officiel 3590 on 19 August 1981, thirty two entries read complete from the page image. That pair of absences does not make it lawful. Article 1 of the 1922 dahir provides that substances are inscribed in tableaux A, B and C by arrêté. Those arrêtés were read on 3 October 2026: tableau B, « Produits stupéfiants », as abrogated and replaced by arrêté n° 1850-96 of 3 September 1996, Bulletin officiel 4422, pages 713 to 716, read in full from the page image, and tableaux A and C as published by arrêté n° 171-66 of 11 March 1966, Bulletin officiel 2817 of 26 October 1966. Cannabidiol is in no entry of that tableau B, whose only cannabis entry is « Cannabis (chanvre indien) et résine de cannabis » in Annexe I, Groupe I, and an OCR text of tableaux A and C of 1966 returns no cannabidiol entry. Arrêtés amending tableau B after 1996, or tableaux A and C after 1966, were searched for and not found, but the gazette was not swept issue by issue, so the list in force today was not established. Cannabidiol has no entry in any instrument read, and entry 10 of the 1971 Convention tableau I is not read as reaching it: on formula alone cannabidiol is a constitutional isomer of the tetrahydrocannabinols, but the entry's chemical designation describes the closed dibenzopyran ring and cannabidiol has that ring open, so this is a reading of the designation and not of the word isomer. Law 13-21 is the instrument that actually bears on this row. It licenses cannabis products for industrial, medical and pharmaceutical ends and caps tetrahydrocannabinol content at a rate « fixé par voie réglementaire ». Arrêté conjoint n° 1297-22 of 12 May 2022, Bulletin officiel 7122 of 1 September 2022, page 1443, fixes that rate for articles 6 and 17 at « un pour cent (1%) », and article 17 provides « A l'exception des produits médicamenteux et pharmaceutiques, est interdite la fabrication de produits dont la teneur en tétrahydrocannabinol (THC) dépasse le taux fixé par voie réglementaire ». That caps what a licensed maker may produce; it does not say that a consumer may buy or hold a CBD product outside the licensed chain, and no provision that does was read.
Confirm directly with Morocco’s national drug authority or your own embassy before you rely on anything.
What Morocco HAS confirmed for related substances
This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.
Before you travel
Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
